Back to Trades
Doshi Dipal
CEO, DirectorCIK: 0001613084
Doshi Dipal, CEO, Director, has filed 3 insider trading reports covering 2 companies. Total disclosed trading volume is $3.0M. Purchases and sales are approximately balanced over this period. The largest single filing involves Entrada Therapeutics, Inc. (TRDA). All transactions sourced from SEC Form 4 filings.
Total Volume
$3.0M
Purchases
$0
Sales
$0
Companies
2
Companies Traded
Trading History (3 filings)
Grant
$0
1 grant
Grant
$157.7K
1 grant
Other
$0